Comparison of Long-Term Survival Between Nivolumab Plus Ipilimumab and Nivolumab Plus Ipilimumab With Chemotherapy in Advanced NSCLC: A Multicenter Retrospective Cohort Study
Kiyohide Komuta, Kinnosuke Matsumoto, Motohiro Tamiya, Takayuki Shiroyama et autres
jp (code pays fourni par la source)